Introduction to DIN-specification 91315 based on the characterization of the plasma jet kINPen® MED

Abstract Standardization is an important tool to reduce costs and risks of research. For the innovative field of plasma medicine, no national or international standards could be identified until now. The present study introduces the first German DIN (German Institute of Standardization)-specification 91315 named “General requirements for medical plasma sources” which was published in June 2014. This developable specification describes obligatory basic criteria for the characterization of different biocompatible cold atmospheric pressure plasma (CAP) sources which are intended supposed for medical applications. With these test methods it is possible to obtain information about performance characteristics as well as effectiveness and safety of medical plasma sources. The suggested biological and physical test methods have been carried out with the CAP jet kINPen® MED. We demonstrate that both test methods described in the DIN-SPEC 91315 are easily to adapt and that the plasma device kINPen® MED is safe and effective with regard to its physical and biological requirements.

[1]  David B. Graves,et al.  The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology , 2012 .

[2]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[3]  W. Stolz,et al.  Cold Atmospheric Air Plasma Sterilization against Spores and Other Microorganisms of Clinical Interest , 2012, Applied and Environmental Microbiology.

[4]  T. von Woedtke,et al.  Time-dependent effects of low-temperature atmospheric-pressure argon plasma on epithelial cell attachment, viability and tight junction formation in vitro , 2012 .

[5]  Ronny Brandenburg,et al.  Atmospheric Pressure Plasma Jet for Medical Therapy: Plasma Parameters and Risk Estimation , 2009 .

[6]  K. Weltmann,et al.  Detection of ozone in a MHz argon plasma bullet jet , 2012 .

[7]  K. Weltmann,et al.  Scar formation of laser skin lesions after cold atmospheric pressure plasma (CAP) treatment: A clinical long term observation , 2013 .

[8]  T. von Woedtke,et al.  Differential Influence of Components Resulting from Atmospheric-Pressure Plasma on Integrin Expression of Human HaCaT Keratinocytes , 2013, BioMed research international.

[9]  J. Ring,et al.  UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. , 1998, Acta dermato-venereologica.

[10]  K. Kraemer,et al.  The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Ruzicka,et al.  High-dose UVA1 radiation therapy for localized scleroderma. , 1997, Journal of the American Academy of Dermatology.

[12]  A. Garner,et al.  Nonthermal Atmospheric Plasma Rapidly Disinfects Multidrug-Resistant Microbes by Inducing Cell Surface Damage , 2012, Antimicrobial Agents and Chemotherapy.

[13]  J. Krutmann,et al.  High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. , 1992, Journal of the American Academy of Dermatology.

[14]  D. Häder,et al.  UV-induced DNA damage and repair: a review , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[15]  Thomas von Woedtke,et al.  Estimation of Possible Mechanisms of Escherichia coli Inactivation by Plasma Treated Sodium Chloride Solution , 2011 .

[16]  T. von Woedtke,et al.  Plasma Applications: A Dermatological View , 2014 .

[17]  Peter Awakowicz,et al.  DBD plasma source operated in single-filamentary mode for therapeutic use in dermatology , 2009 .

[18]  Stephan Reuter,et al.  Plasmas for medicine , 2013 .

[19]  M. Lebowitz,et al.  Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: the AHSMOG Study. , 1999, Environmental research.

[20]  T. Luger,et al.  High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. , 1998, Journal of American Academy of Dermatology.

[21]  Bruce E. Stuck,et al.  Guidelines on limits of exposure to ultraviolet radiation of wavelengths between 180 nm and 400 nm (incoherent optical radiation). , 2004, Health physics.

[22]  B. Saoudi,et al.  Bacterial spore inactivation by atmospheric-pressure plasmas in the presence or absence of UV photons as obtained with the same gas mixture , 2006 .

[23]  T. von Woedtke,et al.  Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. , 2012, The Journal of hospital infection.

[24]  M Moreau,et al.  Non-thermal plasma technologies: new tools for bio-decontamination. , 2008, Biotechnology advances.

[25]  T. Gambichler,et al.  A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. , 2006, Journal of the American Academy of Dermatology.

[26]  M. Jünger,et al.  Antibacterial Activity of an Atmospheric Pressure Plasma Jet Against Relevant Wound Pathogens in vitro on a Simulated Wound Environment , 2010 .

[27]  J. Roth,et al.  Use of a one atmosphere uniform glow discharge plasma to kill a broad spectrum of microorganisms , 1999 .

[28]  T. von Woedtke,et al.  Antimicrobial Effects of UV and VUV Radiation of Nonthermal Plasma Jets , 2009, IEEE Transactions on Plasma Science.

[29]  P. Altmeyer,et al.  Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. , 1999, Journal of the American Academy of Dermatology.

[30]  Ronny Brandenburg,et al.  The Role of Acidification for Antimicrobial Activity of Atmospheric Pressure Plasma in Liquids , 2010 .

[31]  Yasuhiro Matsumura,et al.  Toxic effects of ultraviolet radiation on the skin. , 2004, Toxicology and applied pharmacology.

[32]  Gregor E. Morfill,et al.  Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds. , 2011, Journal of medical microbiology.

[33]  A. Arnold,et al.  In Vitro Susceptibility of Important Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma (DBD) , 2012 .

[34]  M. Jünger,et al.  In Vitro Killing of Clinical Fungal Strains by Low-Temperature Atmospheric-Pressure Plasma Jet , 2011, IEEE Transactions on Plasma Science.

[35]  M. Jünger,et al.  In Vitro Susceptibility of Multidrug Resistant Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma (DBD): In Vitro Susceptibility of Multidrug Resistant Skin and Wound Pathogens… , 2014 .

[36]  T. von Woedtke,et al.  Experimental Recovery of CO2-Laser Skin Lesions by Plasma Stimulation , 2012 .

[37]  C. Oresajo,et al.  Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation‐induced matrix degradation – a review , 2005, International journal of cosmetic science.

[38]  K. Weltmann,et al.  Decontamination of microbiologically contaminated seeds by microwave driven discharge processed gas. , 2012 .

[39]  J. Zimmermann,et al.  Decolonisation of MRSA, S. aureus and E. coli by Cold-Atmospheric Plasma Using a Porcine Skin Model In Vitro , 2012, PloS one.

[40]  M. Kerscher,et al.  Treatment of localised scleroderma by UVA1 phototherapy , 1995, The Lancet.

[41]  S. le Cessie,et al.  A double‐blind placebo‐controlled trial of UVA‐1 in the treatment of dyshidrotic eczema , 2003, Clinical and experimental dermatology.